PubMed Health⌕ Search

Biomedical subjects

E G Iablokov

Publications and source records attributed to E G Iablokov.

At least 19 recordsLinked to original sources

[Dyslipoproteinemia in pancreonecrosis: cause-effect interrelationships].

The work analyzes the results of study of lipid metabolism in 53 patients who underwent operation for pancreatogenic peritonitis. The blood for the test was collected from the portal vein, the hepatic vein, and the aorta which made it possible to appraise metabolism in the liver according to the "entry-exit" blood flow system. It is shown that due to pancreatogenic toxemia, toxemic hepatocytic dyslipoproteinemia develops in patients with pancreonecrosis and persists in the late period. As a consequence of such a condition of lipid metabolism, early atherosclerotic damages to the arteries of the heart and brain and the peripheral arteries occur in patients after pancreonecrosis. The fate of patients was studied 8-10 years after the operation. The nature of atherosclerotic manifestations of toxemic hepatocytic dyslipoproteinemia in the late period after recovery from destructive pancreatitis was determined on the basis of study of central and peripheral hemodynamics.

Arteriosclerosis↗

[Buchwald's operation in the surgery of atherosclerosis obliterans].

Analyzing the world's experience in the surgical management of hyperlipidemias and their own results, the authors make an assessment of Buchwald's operation used in the surgery for atherosclerosis obliterans. The major disadvantage of partial ileac bypass is that there is no prognosis of the operation and its complication. Based on the pathophysiological mechanisms of implementation of Buchwald's operation, the authors have developed a mode of pharmacological simulation of a partial bypass which allows one to predict the effect of the impending intervention and to avoid unjustified operations. The unique procedure also enables the indications for simultaneous interventions to be defined. Ten partial ileac bypass surgeries made by the authors are comprehensively analyzed. Taking into account, the authors propose to choose a treatment of patients with hyperlipidemia and atherosclerosis on an individual basis and to do away with the routine indications for partial ileac bypass surgery.

Arteriosclerosis Obliterans↗

[Rehabilitation of patients following the implantation of an anti-embolism cava filter].

The article analyses the efficacy of rehabilitation measures after implantation of a REPTELA cava-filter in 750 patients in the immediate postimplantation period and in 400 patients in late-term periods of up to 8 years. The average duration of the hospital stage of rehabilitation was 45 days for patients with thromboembolism of the pulmonary artery and 22 days for those without this condition. The application of a complex of rehabilitation measures makes it possible to restore the working capacity of 78.5% of patients with an implanted REPTELA cava-filter.

Humans↗

[Complications after implantation of anti-embolic cava filter].

The article is based on study of the immediate results of REPTELA cava-filter implantation in 750 patients and the late-term results in 400 patients. The incidence of the complications is low. Hematoma at the site of subclavian vein puncture developed in 1.6%, retroperitoneal hematomas in 0.1%, migration of the cava-filter occurred in 0.9% of cases. The main causes of the complications are linked with improper methods of implantation of the cava-filter.

Filtration↗

[Prevention of pulmonary thromboembolism by percutaneous implantation of REPTELA vena cava-filter].

Experience in clinical application of the new antiembolic REPTELA cava-filter is generalized. The immediate (750 patients) and late-term results (400 patients) of implantation of the filter are discussed. Thromboembolism of the pulmonary artery was encountered in the postimplantation period in 1.2% of patients with 0.2% lethality. Technical faults of implantation were the causes of antiembolic inefficacy of the cava-filter.

Equipment Design↗

[State of the ileocaval segment after implantation of the REPTEL antiembolic cava filter].

The condition of the inferior vena cava system was studied in 597 patients after percutaneous implantation of the antiembolic cava-filter on the basis of the clinical findings and results of angiographic and pathoanatomical examination. The patency of the inferior vena cava was found to be maintained in the immediate postimplantation period in most patients. The causes of occlusion of the inferior vena cava in 10% of cases (according to the clinical findings) were embolic occlusion of the cava-filter and ascending thrombosis of the iliocaval segment.

Embolism↗

[Assessment of the results of implantation of an anti-embolic cava-filter using the method of ultrasonic scanning].

By the method of ultrasound scanning, 56 patients were examined at the early and 115 patients at the late period after the percutaneous implantation of a cava-filter. Ultrasound scanning was performed in the cross and longitudinal section planes. In 28 patients, the embolic occlusion of the cava-filter was revealed, in 19-thrombosis of infrarenal inferior vena cava (IVC). Neither migration of the cava-filter, nor damage to the IVC wall was revealed. Ultrasound scanning permits to define the thickness of the IVC wall at the zone of the implanted filter.

Embolism↗

[Ultrasonic diagnosis of thrombosis of the inferior vena cava].

Ultrasonic scanning was used in 115 patients with suspected occlusion of vena cava inferior. Details of ultrasonic diagnosis of non-occlusive and occlusive thrombosis of vena cava inferior and vena cava compression from the outside, monitoring of the thrombosed vena cava and the antiembolic cava filter are discussed.

Diagnosis, Differential↗